Pneumocystis carinii pneumonia in patients with connective tissue diseases: The role of hospital experience in diagnosis and mortality

Arthritis and Rheumatism

Volumn 42, Issue 4, 1999, Pages 780-789

  Ward, Michael M ^a   Donald, Fiona ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCYSTIS PNEUMONIA; POLYARTERITIS NODOSA; POLYMYOSITIS; PRIORITY JOURNAL; REGISTER; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CALIFORNIA; COMORBIDITY; CONNECTIVE TISSUE DISEASES; DERMATOMYOSITIS; FEMALE; HOSPITAL MORTALITY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; POLYARTERITIS NODOSA; POLYMYOSITIS; REGISTRIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; WEGENER GRANULOMATOSIS;

EID: 0032906195     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M     Document Type: Article

References (32)

1. Walzer PD. Pneumocystis carinii - new clinical spectrum? N Engl J Med 1991;324:263-5.
2. LeClair RA. Descriptive epidemiology of interstitial pneumocystis pneumonia: an analysis of 107 cases from the United States, 1955-1967. Am Rev Respir Dis 1969;99:542-7.
3. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features. Ann Intern Med 1974;80; 83-93.
4. Ruskin J, Remington JS. The compromised host and infection. I. Pneumocystis carinii pneumonia. JAMA 1967;202:96-101.
5. Decker JL, Klippel JH, Plotz PH, Steinberg AD. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months. Ann Intern Med 1975;83:606-15.
6. Arend SM, Kroon FP, van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993: an analysis of 78 cases. Arch Intern Med 1995;155:2436-41.
7. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin Proc 1996;71:5-13.
8. Gerrard JG. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995;162:233-5.
9. Oien KA, Black A, Hunter JA, Madhok R. Pneumocystis carinii pneumonia in a patient with rheumatoid arthritis, not on immunosuppressive therapy and in the absence of human immunodeficiency virus infection. Br J Rheumatol 1995;34:677-9.
10. Lemense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994; 150:258-60.
11. Chechani V, Bridges A. Pneumocystis carinii pneumonia in patients with connective tissue disease. Chest 1992;101:375-8.
12. Jarrousse B, Guillevin L, Bindi P, Hachulla E, LeClerc P, Gilson B, et al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 1993;11:615-21.
13. Godeau B, Coutant-Perronne V, Huong DLT, Guillevin L, Magadur G, De Bandt M, et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 1994;21:246-51.
14. Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 1995;151:795-9.
15. Kadoya A, Okada J, Ilkuni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/ dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996;23:1186-8.
16. Forges AJ, Beattie SL, Ritchlin C, Kimberly RP, Christian CL. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol 1992;19:1191-4.
17. Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 1994; 170:198-202.
18. Bennett CL, Garfinkle JB, Greenfield S, Draper D, Rogers W, Mathews C, et al. The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA 1989;261:2975-9.
19. Bennett CL, Adams J, Gertler P, Park RE, Gilman S, George L, et al. Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr Hum Retroviral 1992;5:856-64.
20. Turner BJ, Ball JK. Variations in inpatient mortality for AIDS in a national sample of hospitals. J Acquir Immune Defic Syndr Hum Retroviral 1992;5:978-87.
21. Bennett CL, Adams J, Bennett RL, Rodrique D, George L, Cassibeth B, et al. The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs Hospitals 1987-1991. J Acquir Immune Defic Syndr Hum Retroviral 1995;8:373-8.
22. HCIA. The international classification of diseases, 9th revision, clinical modification: ICD-9-CM. 10th ed. Baltimore: HCIA; 1993.
23. Keeler EB, Rubenstein LV, Kahn KL, Draper D, Harrison ER, McGinty MJ, et al. Hospital characteristics and quality of care. JAMA 1992;268:1709-14.
24. Sen RP, Walsh TE, Fisher W, Brock N. Pulmonary complications of combination therapy with cyclophosphamide and prednisone. Chest 1991;99:143-6.
25. Wollner A, Mohle-Boetani J, Lambert RE, Perruquet JL, Raffin TA, McGuire JL. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis. Thorax 1991;46:205-7.
26. Lang B, Riegel W, Peters T, Peter H-H. Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia. J Rheumatol 1991;18: 1257-9.
27. Porter DR, Marshall DAS, Madhok R, Capell H, Sturrock RD. Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol 1992:31:71-2.
28. Godeau B, Mainardi J-L, Roudot-Thoraval F, Hachulla E, Guillevin L, Du LTH, et al. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis 1995;54:991-4.
29. Cohn SE, Klein JD, Weinstein RA, Shapiro MF, DeHovitz JA, Kessler HA, et al. Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13: 408-15.
30. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984;100:663-71.
31. Limper AH, Offord KP, Smith TF, Martin WJ. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204-9.
32. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994; 32:81-90.